Preliminary Dose-Escalation Results from a Phase 1/2 Study of GEN3014 (HexaBody (R)-CD38) in Patients (pts) with Relapsed or Refractory Multiple Myeloma (RRMM)

Andrew Spencer, Katrine Fladeland Iversen, Binod Dhakal, Maria Creignou, Jenny Chen, Ida H Hiemstra, Sieto Bosgra, Avani Badani, Esther C. W. Breij, Lauren K. Brady, A. Kate Sasser, Anders Malmberg, Henrik Gregersen, Markus Hansson, Annemiek Broijl, Maria-Victoria Mateos, Torben Plesner

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftBlood
Vol/bind140
Udgave nummerSuppl. 1
Sider (fra-til)7320-7321
Antal sider2
ISSN0006-4971
DOI
StatusUdgivet - 15 nov. 2022
Begivenhed64th ASH Annual Meeting & Exposition - Ernest N. Morial Convention or virtually, New Orleans, USA
Varighed: 10 dec. 202213 dec. 2022

Konference

Konference64th ASH Annual Meeting & Exposition
LokationErnest N. Morial Convention or virtually
Land/OmrådeUSA
ByNew Orleans
Periode10/12/202213/12/2022

Citationsformater